FluBlok was licensed by the Food and Drug Administration (FDA) in January 2013. Unlike current production methods for other available seasonal influenza vaccines, FluBlok does not use the influenza virus or chicken eggs in its manufacturing process.
The ACIP recommends that individuals with a severe egg allergy consult with a physician about their allergic conditions prior to vaccination if FluBlok is not available.
Additional information about FluBlok can be found at http://www.cdc.gov/flu/protect/vaccine/qa_flublok-vaccine.htm.
For more information, contact CDC Media Relations at 404-639-3286.